Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

French authorise embryonic stem cell lines:

This article was originally published in Clinica

Executive Summary

The development of new diagnostics and medicines are two of the reasons cited by the French Research Minister, Roger-Gerard Schwartzenberg, for authorising the import of two embryonic stem cell lines on May 3, three days before the government stepped down following the re-election of President Jacques Chirac. His successor will have to confirm or revoke the authorisation, which was made after the lower house of parliament agreed on the principle of research on such cells when it passed the bioethics bill. The bill is unlikely to become law until 2003, but the ready availability to French researchers of the stem cell lines is intended to help speed matters.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT066476

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel